Henry Schein (NASDAQ:HSIC) has been upgraded from Neutral to Buy in a report by Goldman Sachs today.
- Updated: October 11, 2016
Yesterday Henry Schein (NASDAQ:HSIC) traded -1.07% lower at $163.04. HSIC’s 50-day average is $162.66 and its two hundred day average is $170.44. With the last stock price close down -5.36% relative to the two hundred day average, compared with the S&P 500 Index which has decreased -0.01% over the date range. Volume of trade was down over the average, with 346,187 shares of HSIC changing hands under the typical 496,569
Goldman Sachs has upgraded Henry Schein (NASDAQ:HSIC) from Neutral to Buy in a report released on 10/11/2016.
With a total market value of $0, Henry Schein has 52 week low of $140.11 and a 52 week high of $183.00 with a P/E ratio of 27.33 .
In addition to Goldman Sachs reporting its target price, a total of 10 firms have reported on the stock. The consensus target price is $171.80 with 5 firms rating the stock a strong buy, 1 firm rating the stock a buy, 8 firms rating the stock a hold, 0 firms rating the stock a underperform, and finally 0 firms rating the stock a sell.
About Henry Schein (NASDAQ:HSIC)
Henry Schein, Inc. is a provider of health care products and services to office-based dental, animal health and medical practitioners. The Company's segments include healthcare distribution, and technology and value-added services. The healthcare distribution segment aggregates its global dental, animal health and medical operating segments. This segment distributes consumable products, equipment, pharmaceuticals, infection-control products and vitamins. Its global dental group serves office-based dental practitioners, schools and other institutions. The technology and value-added services segment group provides software, technology and other value-added services to health care practitioners. Its technology group offerings include practice management software systems for dental and medical practitioners and animal health clinics. Its value-added practice solutions include financial services on a non-recourse basis, e-services, as well as education services for practitioners.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.